Global, regional, and national burden of inflammatory bowel disease from 1990 to 2021: findings from the Global Burden of Disease 2021
Gastroenterology Report · 11.01.2025 · 13
DOI: 10.1093/gastro/goaf082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Report, online erschienen am 12.09.2025. Verfasst von Gechong Ruan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P…. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key R&D Program of China, National High-Level Hospital Clinical Research Funding, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Background
Inflammatory bowel disease (IBD) imposes a significant economic and social burden. We aimed to assess the burden of IBD globally, regionally, and nationally.
Methods
The incidence, mortality, prevalence, and disability-adjusted life year were obtained from Global Burden of Disease 2021. Estimated annual percentage change, average annual percent change, and age-period-cohort model were used to access trends. Associations between age-standardized rate (ASR) and socio-demographic index were explored. Predictions were made using Bayesian age-period-cohort model and Nordpred.
Results
In 2021, IBD affected 3.8 million people, with ASR of incidence and death of 4.4 and 0.5. The global ASR of incidence increased from 1990 to 2021, while ASR of death, prevalence, and disability-adjusted life year decreased. The age-standardized death rate (ASDR) did not show a significant increase from 2019 to 2021 in most regions and countries. High-incidence regions, such as Western Europe, continued to face significant burdens. East Asian, especially China, was experiencing a sharp increase in incidence. ASR of incidence and death increased with rising socio-demographic index. By 2035, the ASR of incidence and death of IBD will gradually decline.
Conclusion
The global burden of IBD remains severe with changing epidemiological trends. Reducing the burden requires changes in public health policies, disease prevention, and healthcare services.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
ORCID-Profile: Xiaoyin Bai, Hong Yang
Förderung
- National Key R&D Program of China
- National High-Level Hospital Clinical Research Funding
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Ruan, G., Sun, Y., Yu, Z., Bai, X., Yang, H., & Qian, J. (2025). Global, regional, and national burden of inflammatory bowel disease from 1990 to 2021: findings from the Global Burden of Disease 2021. Gastroenterology Report, 13. https://doi.org/10.1093/gastro/goaf082
Vancouver
Ruan G, Sun Y, Yu Z, Bai X, Yang H, Qian J. Global, regional, and national burden of inflammatory bowel disease from 1990 to 2021: findings from the Global Burden of Disease 2021. Gastroenterology Report. 2025;13. doi:10.1093/gastro/goaf082
BibTeX
@article{Ruan2025,
author = {Ruan, Gechong and Sun, Yinghao and Yu, Ziqing and Bai, Xiaoyin and Yang, Hong and Qian, Jiaming},
title = {Global, regional, and national burden of inflammatory bowel disease from 1990 to 2021: findings from the Global Burden of Disease 2021},
journal = {Gastroenterology Report},
year = {2025},
volume = {13},
doi = {10.1093/gastro/goaf082}
}
EUVIMED